Home » Posts tagged with » osimertinib
AstraZeneca gets FDA approval for Tagrisso for type of NSCLC
AstraZeneca has secured extended approval from the US Food and Drug Administration for using Tagrisso (osimertinib) as an adjuvant treatment of non-small cell lung cancer (NSCLC) in patients whose tumors have a certain type of genetic mutation. According to the FDA, nearly 20% of patients with non-small cell lung cancer will have epidermal growth factor […]
Business News Today
- HDFC Bank Q3 20-21 results – Indian private lender reports 18% growth in net profit at $1.2bn
- Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V vaccine
- Bharti Airtel sells stake in Loan Singh creator Seynse Technologies
- Dabur India launches Dabur 100% Pure Cow Ghee
- Infosys to acquire assets of Australian design agency Carter Digital
- ICICI Bank Niyo Bharat Payroll Card launched for MSME workers
- Huntsman wraps up $250m acquisition of Gabriel Performance Products
- Janssen secures DARZALEX FASPRO FDA approval for AL amyloidosis
- Dr. Reddy’s reports success for Russian Covid-19 vaccine Sputnik V
- TCS rolls out Autoscape solution suite for autonomous and connected vehicle experiences
